Abstract Mesenchymal stem cell-based therapies are a promising strategy for the regeneration of articular cartilage and management of knee osteoarthritis (KOA). Nevertheless, the comparative therapeutic efficacy of single versus repeated intra-articular injections of human adipose-derived mesenchymal stem cells (haMSCs) for cartilage preservation in animal models of osteoarthritis, particularly in the lateral and medial femoral condyles and intercondylar fossa, remain unclear.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile